OPRS News and Alerts
Quick Links
OPRS News
8/12/08New Forms Posted to the OPRS Website
8/4/08New Form - Request to Continue Research Intervention
7/23/08Guidance Document & Revised Front Sheet Template
6/19/08New Alert Page Template and Guidance
4/4/08Guidance Document: Consent for Continued Participation in a Research Study By a Young Adult Who Has Reached Age 18
4/1/08New Procedures for Communicating Changes in Study-wide and DF/HCC Accrual Figures to OPRS and the IRB
1/11/08Revised Application for Continuing Review Form
1/2/08National Shortage of Radiopharmaceuticals and Protocols Deviations; Changes to OPRS Forms
10/4/07Priority List Form Addition & Changes to Other Forms Including New Clinical Trials Application Form
7/26/07OPRS Submit Enhancement and Amendment Submission Clarification
7/12/07The Major Deviation/Violation/Exception Form Updated
7/12/07OPRS Submit Enhancement for Dose Escalation Cohort Changes
4/30/07Revised Forms and New Information Sheets Available
4/12/07Overview of Policy Change
11/28/06New OPRS Information Sheet – How to Contact the FDA
11/6/06Various OPRS Update Highlights (compliance updates and more)
9/19/06 Preparing Endorsement Letters for New Protocols
9/11/06 ONCPRO Enhancement for New User Sign Up
8/24/06Directed To Principal Investigators And Study Staff Of Protocols That Involve Tissue Collection
8/11/2006The following news update from OPRS highlights CTEP CTCAE v3.0 Adverse Event Lay Terms
6/20/2006The following news update from OPRS highlights new templates, letters and OPRS staff members
4/27/2006 The following news update from OPRS highlights various issues relating to protocol submissions and post-approval protocol events
4/13/06OPRS Submit Changes with Violations, Deviations and Exceptions
2/13/06DFCI Policy on Reporting Deviations/ Violations/ Exceptions to OPRS